The Goal: Zero by 30

September 27, 2017

By Peter Hodge, Director of Investor Relations & Market Research September 28th is World Rabies Day, a worldwide health observance started in 2007 by the…

Read More

Sled Dog Evolution

September 26, 2017

By: Michael K. Guy, DVM, MS, PhD, Vice President and Clinical Veterinarian Archeologists working on a remote island in northern Siberia have found what may…

Read More

Dairy Farming & Food Safety

September 19, 2017

By Andre Teixeira, DVM, PhD, Director of Veterinary Affairs Milk and milk-derived products can be an important source of nutrients and microorganisms that are beneficial to…

Read More

Disaster preparedness for all creatures, large and small

September 8, 2017

By Rocky Ordoñez, Digital Marketing Coordinator, Jaguar Health In the late summer of 1992, Hurricane Andrew wailed and hammered away while I hunkered down with…

Read More

Humans, Horses, and Emotion

September 5, 2017

By Meredith Kahn, MS, Sales & Marketing Manager, Jaguar Health Did you know that horses have an incredible capacity for emotion? In fact, horses can…

Read More

August 26th is National Dog Day!

August 26, 2017

By Peter Hodge, Director of Investor Relations & Market Research Part of Jaguar’s staff contribution series National Dog Day, celebrated on August 26th annually to…

Read More

Who’s more related? A whale and a manatee or a whale and a cow?

August 15, 2017

By Daniel Lin, Sales & Digital Marketing Summer Intern What do whales and cows have in common? Aside from their color schemes, research indicates that…

Read More

Today we celebrate cats!

August 8, 2017

In honor of International Cat Day* here are 20 fun (and unusual!) facts about the world’s favorite feline companion! Compiled by Joelle Margolin, Esq., Vice President of…

Read More

  • 1
  • 2
  • 3
  • 4
  • 5
  • 7

MYTESI® is an antidiarrheal indicated for the symptomatic relief of noninfectious diarrhea in adult patients with HIV/AIDS on antiretroviral therapy (ART).

Important Safety Information about MYTESI®
MYTESI® is not indicated for the treatment of infectious diarrhea. Rule out infectious etiologies of diarrhea before starting MYTESI®.

If infectious etiologies are not considered, there is a risk that patients with infectious etiologies will not receive the appropriate therapy and their disease may worsen. In clinical studies, the most common adverse reactions occurring at a rate greater than placebo were upper respiratory tract infection (5.7%), bronchitis (3.9%), cough (3.5%), flatulence (3.1%), and increased bilirubin (3.1%).

Click to Read Full Prescribing Information